Quanterix (NASDAQ:QTRX) Shares Down 5% – Here’s Why

by · The Cerbat Gem

Quanterix Co. (NASDAQ:QTRXGet Free Report)’s share price dropped 5% during trading on Wednesday . The stock traded as low as $14.41 and last traded at $14.41. Approximately 20,247 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 396,062 shares. The stock had previously closed at $15.17.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on QTRX shares. Scotiabank cut their target price on Quanterix from $32.00 to $28.00 and set a “sector outperform” rating on the stock in a research report on Monday, August 12th. TD Cowen upped their target price on shares of Quanterix from $13.50 to $16.00 and gave the stock a “hold” rating in a research note on Wednesday.

Read Our Latest Report on QTRX

Quanterix Stock Down 15.3 %

The stock has a 50-day moving average of $12.97 and a 200 day moving average of $14.03. The company has a market capitalization of $493.17 million, a PE ratio of -12.00 and a beta of 1.36.

Insider Buying and Selling at Quanterix

In related news, Director David R. Walt purchased 47,000 shares of the firm’s stock in a transaction dated Tuesday, August 20th. The stock was bought at an average price of $13.29 per share, for a total transaction of $624,630.00. Following the purchase, the director now directly owns 1,487,342 shares in the company, valued at approximately $19,766,775.18. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 6.90% of the company’s stock.

Institutional Investors Weigh In On Quanterix

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Price T Rowe Associates Inc. MD increased its holdings in shares of Quanterix by 3.1% in the first quarter. Price T Rowe Associates Inc. MD now owns 39,916 shares of the company’s stock worth $941,000 after purchasing an additional 1,186 shares during the period. Allspring Global Investments Holdings LLC grew its holdings in shares of Quanterix by 11.0% during the second quarter. Allspring Global Investments Holdings LLC now owns 14,261 shares of the company’s stock worth $188,000 after purchasing an additional 1,417 shares in the last quarter. Hsbc Holdings PLC increased its position in shares of Quanterix by 34.7% in the second quarter. Hsbc Holdings PLC now owns 12,738 shares of the company’s stock valued at $164,000 after acquiring an additional 3,279 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in Quanterix by 42.1% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 14,341 shares of the company’s stock worth $338,000 after buying an additional 4,250 shares during the period. Finally, Emerald Mutual Fund Advisers Trust increased its stake in shares of Quanterix by 0.8% during the third quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company’s stock valued at $7,300,000 after buying an additional 4,406 shares during the period. Institutional investors own 86.48% of the company’s stock.

Quanterix Company Profile

(Get Free Report)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.

Read More